Puente de Domingo Flórez (ES) Cancer Clinical Trials

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

~72 mi. (Ourense, Spain, +156 more cities)

Complejo Hospitalario Universitario Ourense /ID# 222876

IGH-CCND1 Fusion, +1 more biomarker

Multiple Myeloma

dexamethasone, +1 more drug

chemotherapy, +1 more type

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

~72 mi. (Ourense, Spain, +97 more cities)

Complejo Hospitalario Universitario de Orense

Microsatellite Stable (MSS)

Colorectal Adenocarcinoma

bevacizumab, +2 more drugs

chemotherapy, +1 more type

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~75 mi. (Lugo, Spain, +130 more cities)

Hospital Universitario Lucus Augusti ( Site 0852)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

~75 mi. (Lugo, Spain, +190 more cities)

Hospital Universitario Lucus Augusti

ATM Loss, +27 more biomarkers

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL

~87 mi. (León, Spain, +10 more cities)

Complejo Asistencial Universitario De León

ER Positive, +2 more biomarkers

Breast Carcinoma

abemaciclib, +2 more drugs

hormone therapy, +1 more type

Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE

~93 mi. (Tene, Spain, +41 more cities)

Hospital Universitario de Canarias

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

cytarabine, +8 more drugs

chemotherapy, +2 more types

A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression

~93 mi. (Tene, Spain, +7 more cities)

Hospital Universitario de Canarias

ER Positive, +2 more biomarkers

Breast Adenocarcinoma

patritumab deruxtecan

chemotherapy, +1 more type

Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors.

~93 mi. (Tene, Spain, +5 more cities)

Hospital Universitario de Canarias

Gastrointestinal Stromal Tumor

imatinib, +1 more drug

targeted therapy